VSee Health, Inc. Proceeds from Related Party Debt
VSee Health, Inc. (VSEE) reported Proceeds from Related Party Debt of $190.00 thousand for the 12-month period ending 2023-12-31, per its 10-K/A filed 2025-08-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2025-08-29
- VSee Health, Inc. proceeds from related party debt for the quarter ending 2023-12-31 was $70.00K.
- VSee Health, Inc. proceeds from related party debt for the quarter ending 2023-09-30 was $0.00.
- VSee Health, Inc. proceeds from related party debt for the quarter ending 2023-06-30 was -$130.00K.
- VSee Health, Inc. proceeds from related party debt for the quarter ending 2023-03-31 was $250.00K.
- VSee Health, Inc. proceeds from related party debt for fiscal 2023 was $190.00K, a 45.71% decline from fiscal 2022.
- VSee Health, Inc. proceeds from related party debt for fiscal 2022 was $350.00K.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 4 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 6 month as first filed | Proceeds from Related Party Debt 7 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 9 month as first filed | Proceeds from Related Party Debt 12 month | Proceeds from Related Party Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $70.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $70.00K derived: sum of 2 quarters · filed 2025-08-29 | -$60.00K derived: sum of 3 quarters · filed 2025-08-29 | $190.00K 10-K/A · filed 2025-08-29 | $576.50K 10-K · filed 2024-04-12 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$130.00K derived: sum of 2 quarters · filed 2024-11-14 | $120.00K 10-Q · filed 2024-11-14 | $576.50K 10-Q · filed 2023-11-20 | |||||
| 2023-06-30 | -$130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-23 | $120.00K 10-Q · filed 2024-09-23 | $565.00K 10-Q · filed 2023-08-21 | ||||||
| 2023-03-31 | $250.00K 10-Q · filed 2023-05-15 | ||||||||
| 2022-12-31 | $350.00K 10-K · filed 2024-04-12 | ||||||||
| 2021-12-31 | $149.95K 10-K · filed 2023-04-12 | ||||||||
| 2021-09-30 | $124.95K 10-Q · filed 2022-11-10 | ||||||||
| 2021-06-30 | $74.78K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |